Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kwan Soo Ko is active.

Publication


Featured researches published by Kwan Soo Ko.


Science | 2011

Rapid Pneumococcal Evolution in Response to Clinical Interventions

Nicholas J. Croucher; Simon R. Harris; Christophe Fraser; Michael A. Quail; John Burton; Mark van der Linden; Lesley McGee; Anne von Gottberg; Jae-Hoon Song; Kwan Soo Ko; Bruno Pichon; Stephen Baker; Christopher M. Parry; Lotte Lambertsen; Dea Shahinas; Dylan R. Pillai; Timothy J. Mitchell; Gordon Dougan; Alexander Tomasz; Keith P. Klugman; Julian Parkhill; William P. Hanage; Stephen D. Bentley

Streptococcus pneumonia evades vaccines and drugs by high levels of recombination and rapid adaptation. Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain23F-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.


Antimicrobial Agents and Chemotherapy | 2009

Classification of staphylococcal cassette chromosome mec (SCCmec) : guidelines for reporting novel SCCmec elements.

Teruyo Ito; Keiichi Hiramatsu; D. Oliviera; H. de Lencastre; Kunyan Zhang; Henrik Westh; Frances G. O'Brien; Philip M. Giffard; David C. Coleman; Fred C. Tenover; Susan Boyle-Vavra; Robert Skov; Mark C. Enright; Barry N. Kreiswirth; Kwan Soo Ko; Hajo Grundmann; Frédéric Laurent; Johanna U. Ericson Sollid; Angela M. Kearns; Richard V. Goering; Joseph F. John; Robert S. Daum; Bo Söderquist

Classification of staphylococcal cassette chromosome mec (SCCmec) : guidelines for reporting novel SCCmec elements.


Antimicrobial Agents and Chemotherapy | 2004

High Prevalence of Antimicrobial Resistance among Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study)

Jae-Hoon Song; Sook-In Jung; Kwan Soo Ko; Nayoung Kim; Jun Seong Son; Hyun-Ha Chang; Hyun Kyun Ki; Won Sup Oh; Ji Yoeun Suh; Kyong Ran Peck; Nam Yong Lee; Yonghong Yang; Quan Lu; Anan Chongthaleong; Cheng-Hsun Chiu; M. K. Lalitha; Jennifer Perera; Ti Teow Yee; Gamini Kumarasinghe; Farida Jamal; Adeeba Kamarulzaman; Parasakthi N; Pham Hung Van; Celia C. Carlos; Thomas So; Tak Keung Ng; Atef M. Shibl

ABSTRACT A total of 685 clinical Streptococcus pneumoniae isolates from patients with pneumococcal diseases were collected from 14 centers in 11 Asian countries from January 2000 to June 2001. The in vitro susceptibilities of the isolates to 14 antimicrobial agents were determined by the broth microdilution test. Among the isolates tested, 483 (52.4%) were not susceptible to penicillin, 23% were intermediate, and 29.4% were penicillin resistant (MICs ≥ 2 mg/liter). Isolates from Vietnam showed the highest prevalence of penicillin resistance (71.4%), followed by those from Korea (54.8%), Hong Kong (43.2%), and Taiwan (38.6%). The penicillin MICs at which 90% of isolates are inhibited (MIC90s) were 4 mg/liter among isolates from Vietnam, Hong Kong, Korea, and Taiwan. The prevalence of erythromycin resistance was also very high in Vietnam (92.1%), Taiwan (86%), Korea (80.6%), Hong Kong (76.8%), and China (73.9%). The MIC90s of erythromycin were >32 mg/liter among isolates from Korea, Vietnam, China, Taiwan, Singapore, Malaysia, and Hong Kong. Isolates from Hong Kong showed the highest rate of ciprofloxacin resistance (11.8%), followed by isolates from Sri Lanka (9.5%), the Philippines (9.1%), and Korea (6.5%). Multilocus sequence typing showed that the spread of the Taiwan19F clone and the Spain23F clone could be one of the major reasons for the rapid increases in antimicrobial resistance among S. pneumoniae isolates in Asia. Data from the multinational surveillance study clearly documented distinctive increases in the prevalence rates and the levels of antimicrobial resistance among S. pneumoniae isolates in many Asian countries, which are among the highest in the world published to date.


Proceedings of the National Academy of Sciences of the United States of America | 2008

Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus

Ulrich Nübel; Philippe Roumagnac; Mirjam Feldkamp; Jae-Hoon Song; Kwan Soo Ko; Yhu Chering Huang; Geoffrey W. Coombs; Margaret Ip; Henrik Westh; Robert Skov; Marc Struelens; Richard V. Goering; Birgit Strommenger; Annette Weller; Wolfgang Witte; Mark Achtman

A small number of clonal lineages dominates the global population structure of methicillin-resistant Staphylococcus aureus (MRSA), resulting in the concept that MRSA has emerged on a few occasions after penicillinase-stable β-lactam antibiotics were introduced to clinical practice, followed by intercontinental spread of individual clones. We investigated the evolutionary history of an MRSA clone (ST5) by mutation discovery at 108 loci (46 kb) within a global collection of 135 isolates. The SNPs that were ascertained define a radial phylogenetic structure within ST5 consisting of at least 5 chains of mutational steps that define geographically associated clades. These clades are not concordant with previously described groupings based on staphylococcal protein A gene (spa) typing. By mapping the number of independent imports of the staphylococcal cassette chromosome methicillin-resistance island, we also show that import has occurred on at least 23 occasions within this single sequence type and that the progeny of such recombinant strains usually are distributed locally rather than globally. These results provide strong evidence that geographical spread of MRSA over long distances and across cultural borders is a rare event compared with the frequency with which the staphylococcal cassette chromosome island has been imported.


Journal of Antimicrobial Chemotherapy | 2011

Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study

Jae-Hoon Song; Po-Ren Hsueh; Doo Ryeon Chung; Kwan Soo Ko; Cheol-In Kang; Kyong Ran Peck; Joon-Sup Yeom; Shin Woo Kim; Hyun-Ha Chang; Yeon-Sook Kim; Sook-In Jung; Jun Seong Son; Thomas So; M. K. Lalitha; Yonghong Yang; Shao-Guang Huang; Hui Wang; Quan Lu; Celia C. Carlos; Jennifer Perera; Cheng-Hsun Chiu; Jien-Wei Liu; Anan Chongthaleong; Visanu Thamlikitkul; Pham Hung Van; Hyuck Lee; Thomas M. K. So; David Jien-Wei Liu; Dilip Mathai; Tran Van Ngoc

OBJECTIVES Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in hospitals in many Asian countries. Recent emergence of community-associated (CA) MRSA worldwide has added another serious concern to the epidemiology of S. aureus infections. To understand the changing epidemiology of S. aureus infections in Asian countries, we performed a prospective, multinational surveillance study with molecular typing analysis. METHODS We evaluated the prevalence of methicillin resistance in S. aureus isolates in CA and healthcare-associated (HA) infections, and performed molecular characterization and antimicrobial susceptibility tests of MRSA isolates. RESULTS MRSA accounted for 25.5% of CA S. aureus infections and 67.4% of HA infections. Predominant clones of CA-MRSA isolates were ST59-MRSA-SCCmec type IV-spa type t437, ST30-MRSA-SCCmec type IV-spa type t019 and ST72-MRSA-SCCmec type IV-spa type t324. Previously established nosocomial MRSA strains including sequence type (ST) 239 and ST5 clones were found among CA-MRSA isolates from patients without any risk factors for HA-MRSA infection. CA-MRSA clones such as ST59, ST30 and ST72 were also isolated from patients with HA infections. CONCLUSIONS Our findings confirmed that MRSA infections in the community have been increasing in Asian countries. Data also suggest that various MRSA clones have spread between the community and hospitals as well as between countries.


Antimicrobial Agents and Chemotherapy | 2012

Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

So Hyun Kim; Jae-Hoon Song; Doo Ryeon Chung; Visanu Thamlikitkul; Yonghong Yang; Hui Wang; Min Lu; Thomas So; Po-Ren Hsueh; Rohani Md Yasin; Celia C. Carlos; Hung Van Pham; M. K. Lalitha; Nobuyuki Shimono; Jennifer Perera; Atef M. Shibl; Jin Yang Baek; Cheol-In Kang; Kwan Soo Ko; Kyong Ran Peck

ABSTRACT Antimicrobial resistance in Streptococcus pneumoniae remains a serious concern worldwide, particularly in Asian countries, despite the introduction of heptavalent pneumococcal conjugate vaccine (PCV7). The Asian Network for Surveillance of Resistant Pathogens (ANSORP) performed a prospective surveillance study of 2,184 S. pneumoniae isolates collected from patients with pneumococcal infections from 60 hospitals in 11 Asian countries from 2008 to 2009. Among nonmeningeal isolates, the prevalence rate of penicillin-nonsusceptible pneumococci (MIC, ≥4 μg/ml) was 4.6% and penicillin resistance (MIC, ≥8 μg/ml) was extremely rare (0.7%). Resistance to erythromycin was very prevalent in the region (72.7%); the highest rates were in China (96.4%), Taiwan (84.9%), and Vietnam (80.7%). Multidrug resistance (MDR) was observed in 59.3% of isolates from Asian countries. Major serotypes were 19F (23.5%), 23F (10.0%), 19A (8.2%), 14 (7.3%), and 6B (7.3%). Overall, 52.5% of isolates showed PCV7 serotypes, ranging from 16.1% in Philippines to 75.1% in Vietnam. Serotypes 19A (8.2%), 3 (6.2%), and 6A (4.2%) were the most prominent non-PCV7 serotypes in the Asian region. Among isolates with serotype 19A, 86.0% and 79.8% showed erythromycin resistance and MDR, respectively. The most remarkable findings about the epidemiology of S. pneumoniae in Asian countries after the introduction of PCV7 were the high prevalence of macrolide resistance and MDR and distinctive increases in serotype 19A.


Journal of Clinical Microbiology | 2005

Distribution of Major Genotypes among Methicillin-Resistant Staphylococcus aureus Clones in Asian Countries

Kwan Soo Ko; Ji-Young Lee; Ji Yoeun Suh; Won Sup Oh; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song

ABSTRACT To investigate the evolutionary pattern and genotypic characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains in the Asian region, 74 MRSA strains isolated from 12 Asian countries were analyzed by multilocus sequence typing (MLST) and SCCmec typing. Overall, a total of 16 genotypes based on sequence type and SCCmec types were identified among MRSA strains from Asian countries. Data revealed two major genotypes of MRSA strains in Asia, with unique geographic distributions. By MLST analysis, all strains from Korea and Japan except one belonged to clonal complex 5 (CC5) while most MRSA isolates from other Asian countries belonged to CC239. SCCmec typing showed that most isolates from Korea and Japan were SSmec type II whereas SCCmec type III (or IIIA) was the most common type in strains from other Asian countries. Our data documented a unique geographic distribution and evolutionary pattern of MRSA clones in Asia.


American Journal of Respiratory and Critical Care Medicine | 2011

High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia

Doo Ryeon Chung; Jae-Hoon Song; So Hyun Kim; Visanu Thamlikitkul; Shao Guang Huang; Hui Wang; Thomas So; Rohani Md Yasin; Po-Ren Hsueh; Celia C. Carlos; Li Yang Hsu; Latre Buntaran; M. K. Lalitha; Min Ja Kim; Jun Yong Choi; Sang Il Kim; Kwan Soo Ko; Cheol-In Kang; Kyong Ran Peck

RATIONALE Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) remain important causes of morbidity and mortality. Increasing antimicrobial resistance has aroused the concern of the failure of antibiotic treatment. OBJECTIVES To determine the distribution of the bacterial isolates of HAP and VAP, their antimicrobial resistance patterns, and impact of discordant antibiotic therapy on clinical outcome in Asian countries METHODS A prospective surveillance study was conducted in 73 hospitals in 10 Asian countries from 2008-2009. A total of 2,554 cases with HAP or VAP in adults were enrolled and 2,445 bacterial isolates were collected from 1,897 cases. Clinical characteristics and antimicrobial resistance profiles were analyzed. MEASUREMENT AND MAIN RESULTS Major bacterial isolates from HAP and VAP cases in Asian countries were Acinetobacter spp., Pseudomonas aeruginosa, Staphylococcus aureus, and Klebsiella pneumoniae. Imipenem resistance rates of Acinetobacter and P. aeruginosa were 67.3% and 27.2%, respectively. Multidrug-resistant rates were 82% and 42.8%, and extensively drug-resistant rates were 51.1% and 4.9%. Multidrug-resistant rate of K. pneumoniae was 44.7%. Oxacillin resistance rate of S. aureus was 82.1%. All-cause mortality rate was 38.9%. Discordant initial empirical antimicrobial therapy increased the likelihood of pneumonia-related mortality (odds ratio, 1.542; 95% confidence interval, 1.127-2.110). CONCLUSIONS Acinetobacter spp., P. aeruginosa, S. aureus, and K. pneumoniae are the most frequent isolates from adults with HAP or VAP in Asian countries. These isolates are highly resistant to major antimicrobial agents, which could limit the therapeutic options in the clinical practice. Discordant initial empirical antimicrobial therapy significantly increases the likelihood of pneumonia-related mortality.


International Journal of Antimicrobial Agents | 2008

Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens.

Jae-Hoon Song; Won Sup Oh; Cheol-In Kang; Doo Ryeon Chung; Kyong Ran Peck; Kwan Soo Ko; Joon-Sup Yeom; Choon Kwan Kim; Shin Woo Kim; Hyun-Ha Chang; Yeon-Sook Kim; Sook-In Jung; Zhaohui Tong; Qingtao Wang; Shao-Guang Huang; Jien-Wei Liu; M. K. Lalitha; Ban-Hock Tan; Pham Hung Van; Celia C. Carlos; Thomas So

Abstract Appropriate antimicrobial treatment of community-acquired pneumonia (CAP) should be based on the distribution of aetiological pathogens, antimicrobial resistance of major pathogens, clinical characteristics and outcomes. We performed a prospective observational study of 955 cases of adult CAP in 14 hospitals in eight Asian countries. Microbiological evaluation to determine etiological pathogens as well as clinical evaluation was performed. Bronchopulmonary disease (29.9%) was the most frequent underlying disease, followed by cardiovascular diseases (19.9%), malignancy (11.7%) and neurological disorder (8.2%). Streptococcus pneumoniae (29.2%) was the most common isolate, followed by Klebsiella pneumoniae (15.4%) and Haemophilus influenzae (15.1%). Serological tests were positive for Mycoplasma pneumoniae (11.0%) and Chlamydia pneumoniae (13.4%). Only 1.1% was positive for Legionella pneumophila by urinary antigen test. Of the pneumococcal isolates, 56.1% were resistant to erythromycin and 52.6% were not susceptible to penicillin. Seventeen percent of CAP had mixed infection, especially S. pneumoniae with C. pneumoniae. The overall mortality rate was 7.3%, and nursing home residence, mechanical ventilation, malignancy, cardiovascular diseases, respiratory rate>30/min and hyponatraemia were significant independent risk factors for mortality by multivariate analysis (P <0.05). The current data provide relevant information about pathogen distribution and antimicrobial resistance of major pathogens of CAP as well as clinical outcomes of illness in Asian countries.


Antimicrobial Agents and Chemotherapy | 2012

Guidelines for Reporting Novel mecA Gene Homologues

Teruyo Ito; Keiichi Hiramatsu; Alexander Tomasz; Hermínia de Lencastre; Vincent Perreten; Matthew T. G. Holden; David C. Coleman; Richard V. Goering; Philip M. Giffard; Robert Skov; Kunyan Zhang; Henrik Westh; Frances G. O'Brien; Fred C. Tenover; Duarte C. Oliveira; Susan Boyle-Vavra; Frédéric Laurent; Angela M. Kearns; Barry N. Kreiswirth; Kwan Soo Ko; Hajo Grundmann; Johanna U. Ericson Sollid; Joseph F. John; Robert S. Daum; Bo Söderquist; Girbe Buist

Methicillin-resistant staphylococci are disseminated all over the world and are frequent causes of health care- and community-associated infections. Methicillin-resistant strains typically carry the acquired mecA gene that encodes a low-affinity penicillin-binding protein (PBP), designated PBP2a or

Collaboration


Dive into the Kwan Soo Ko's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nam Yong Lee

Chungnam National University

View shared research outputs
Top Co-Authors

Avatar

Won Sup Oh

Kangwon National University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ji-Young Lee

Gyeongsang National University

View shared research outputs
Top Co-Authors

Avatar

Ki Tae Kwon

Samsung Medical Center

View shared research outputs
Top Co-Authors

Avatar

Sook-In Jung

Chonnam National University

View shared research outputs
Researchain Logo
Decentralizing Knowledge